26 June 2019

The Venture Challenge is a 10-week program to develop an initial idea – a breakthrough research result – into a solid business case. Participate and learn to build a customer value proposition, identify key risks and assumptions, develop a validation and de-risking strategy, build and pitch a Venture Plan and get connected to Life Sciences experts, investors and seasoned entrepreneurs.

Over the last 10 years the Venture Challenge has proven to be a successful startup programme in Therapeutics, Diagnostics and Medical Devices. See who participated in the previous 21 Venture Challenge editions and read about the success of  10 years Venture Challenge.

How it works?
The Venture Challenge consists of a series of bootcamps and coaching sessions; it takes around three months from start to finish. Guided by a dedicated team of experienced trainers and challenged by your peers and industry experts you will translate your invention into a viable business idea.
After the bootcamps and coaching sessions you will be introduced to representatives of all relevant early stage life Sciences investors and you pitch your venture to the Venture Challenge jury, consisting of seasoned entrepreneurs and investors, who will then decide who takes home the €25,000 prize money. The winner of the Venture Challenge will be publically announced at a large life sciences business conference offering great exposure.

Read about the valuable programme in detail and download the Venture Challenge Factsheet or view the Venture Challenge animation they have made a couple of years ago.

If you are interested please contact Louise Hoppel, Dept. of Valorization. 

More information: link. 

 

Related news items


Radboud-led collaboration generates innovative candidate drug against malaria

19 September 2019

A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end.

read more

Radboud university medical center opens first healthcare AI labs

19 September 2019

These are the first two ‘labs’ in the east of the Netherlands that are part of the national Innovation Center for Artificial Intelligence and the first health labs. With these two initiatives, Radboudumc and its partners are investing heavily in the application of AI to health care.

read more

Careful prescription of addictive painkillers still necessary

19 September 2019

Although the use of opioid painkillers in the Netherlands has risen over the past ten years, it is nowhere near the degree to which they are used in the United States, say Arnt Schellekens and his colleagues in an article published in The Lancet Public Health.

read more

Exercising at home has a positive effect on Parkinson's patients

19 September 2019

In a large double-blind study, Radboudumc researchers show that patients in the early stages of Parkinson's disease can exercise regularly at home for 6 months.

read more

A personal touch of Kartika Hapsari

18 September 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Kartika Hapsari.

read more

Healthy weight limits risk of dementia even in old age

17 September 2019

Even late in life it makes sense to maintain a healthy weight, and thus to limit the risk of cognitive decline.

read more